Telix Pharmaceuticals

About:

Telix Pharmaceuticalsis a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.

Website: http://www.telixpharma.com

Twitter/X: TelixPharma

Top Investors: Australian Government

Description:

Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer.

Total Funding Amount:

$495M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Melbourne, Victoria, Australia

Founded Date:

2015-11-01

Contact Email:

info(AT)telixpharma.com

Founders:

Christian Behrenbruch

Number of Employees:

101-250

Last Funding Date:

2024-07-23

IPO Status:

Public

Industries:

Biotechnology

© 2025 bioDAO.ai